Nightingale Health Oyj (FRA:7XE)

Market Cap	70.75M -53.2%
Revenue (ttm)	5.50M +17.2%
Net Income	-18.47M
EPS	-0.31
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	1.035
Previous Close	1.070
Day's Range	1.035 - 1.035
52-Week Range	0.672 - 2.410
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 16, 2026

About Nightingale Health Oyj

Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, Europe, the Middle East, Africa, AMER, and the Asia-Pacific. The company’s Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely, as well as multiomics analysis services. It provides its services to research programs, universities, and healthcare providers. The company has a collaboration with Personalised Health...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2002
• Employees: 101
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7XE

Financial Performance

In fiscal year 2026, Nightingale Health Oyj's revenue was 5.50 million, an increase of 17.24% compared to the previous year's 4.69 million. Losses were -18.47 million, 0.06% more than in 2025.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 15, 2026

Data Sources Report a data error